Loading BSD 13F portfolios...
Elite Manager Tracking
The Top 150 BSDs
Real-time 13F holding analysis for the industry's most influential institutional investors. Track conviction shifts, new entries, and structural exits.
Marc R. Schneidman
✓ VerifiedInstitutional Investor • Aquilo Capital Management
Value
$650M
Stocks
13 Stocks (2 new)
Turnover
44.0%
Top Holdings
AMGN(33.51%) BPMC(13.32%) ARWR(12.57%) PTGX(7.08%) KYMR(6.80%)
About Investor
Established investor leading Aquilo Capital Management, with expertise in fundamental analysis and long-term value creation. Has built a strong track record by focusing on fundamental research and maintaining a consistent investment approach through various market environments.
Investor Philosophy
Investment philosophy details pending verification.
Marc R. Schneidman Top Holdings
| Ticker | P/C | Company Name | Sector | Market Value | Shares | Weight | Chg Shares | % Chg |
|---|---|---|---|---|---|---|---|---|
| AMGN | None | Amgen Inc | Health Care | $18.7M | 60,000 | 33.5% | 35K | +140.0% |
| BPMC | None | Blueprint Medicines Corporation | General | $7.4M | 83,926 | 13.3% | -46K | -35.2% |
| ARWR | None | ARROWHEAD PHARMACEUTICALS IN | General | $7.0M | 550,130 | 12.6% | -157K | -22.3% |
| PTGX | None | Protagonist Therapeutics, Inc. | Health Care | $4.0M | 81,692 | 7.1% | 5K | +6.7% |
| KYMR | None | Kymera Therapeutics, Inc. | General | $3.8M | 138,521 | 6.8% | -45K | -24.5% |
| DTIL | None | Precision BioSciences, Inc. | Health Care | $3.5M | 726,149 | 6.2% | 190K | +35.4% |
| ARVN | None | Arvinas | General | $2.5M | 360,766 | 4.5% | 32K | +9.7% |
| RGNX | None | REGENXBIO INC | General | $1.9M | 271,302 | 3.5% | -75K | -21.7% |
| ACET | None | ADICET BIO INC | General | $1.9M | 2.46M | 3.3% | -75K | -3.0% |
| BCYC | None | BICYCLE THERAPEUTICS PLC | General | $1.5M | 171,695 | 2.6% | -50K | -22.6% |
Recent Buys (13F)
Recent Sells (13F)
| Ticker | Amount | % Chg | Weight | Status |
|---|---|---|---|---|
| BPMCBlueprint Medicines Corporation | $7.4M | -35.2% | 13.3% | Decreased |
| ARWRARROWHEAD PHARMACEUTICALS IN | $7.0M | -22.3% | 12.6% | Decreased |
| KYMRKymera Therapeutics, Inc. | $3.8M | -24.5% | 6.8% | Decreased |
| SLNSILENCE THERAPEUTICS PLC | $2.5M | -100.0% | 0.0% | Sold Out |
| RGNXREGENXBIO INC | $1.9M | -21.7% | 3.5% | Decreased |
| ACETADICET BIO INC | $1.9M | -3.0% | 3.3% | Decreased |
| BCYCBICYCLE THERAPEUTICS PLC | $1.5M | -22.6% | 2.6% | Decreased |
| IMTXImmatics N.V. | $1.4M | -18.4% | 2.5% | Decreased |
13F Sector Breakdown
General53.2%
Health Care46.8%
| Sector | Stocks | Value | Exposure |
|---|---|---|---|
| General | 10 | $29.7M | 53.2% |
| Health Care | 3 | $26.1M | 46.8% |